Celltrion Named Preferred Bidder to Acquire U.S. Plant Amid Tariff Concerns
Seoul: Celltrion Inc., a leading South Korean biopharmaceutical company, announced that it has been selected as the preferred bidder to acquire a biopharmaceutical manufacturing facility